8-K: Navient to Sell Healthcare Services Business to CorroHealth for $365 Million

Navient Corporation has agreed to sell its Healthcare Services business, Xtend Healthcare, to CorroHealth for $365 million in cash, marking a significant step in the company's simplification strategy.

Summary

• Navient Corporation has entered into a Sale and Purchase Agreement with Coding Solutions Acquisition, Inc. (CorroHealth) to sell its equity interests in Xtend Healthcare, LLC.
• The transaction is valued at $365 million in cash, subject to customary adjustments.
• This sale is part of Navient's ongoing plan to simplify the company, reduce expenses, and enhance flexibility.
• The deal is expected to close by the end of September 2024, pending customary closing conditions.
• Approximately 950 employees of Xtend Healthcare will join CorroHealth as part of the agreement.
• As of June 30, 2024, the book value of the Healthcare Services business was approximately $136 million, including $113 million of goodwill and acquired intangible assets.
• Navient is also in discussions about the potential sale of its Government Services businesses, which had a book value of approximately $192 million as of June 30, 2024.

Sentiment

Score: 7

Explanation: The sentiment is positive due to the strategic move to simplify the company and the cash infusion from the sale. However, there is some uncertainty regarding the net gain and the potential sale of the Government Services business, which tempers the overall sentiment.

Positives

• The sale of the Healthcare Services business aligns with Navient's strategic objectives to simplify the company and reduce its expense base.
• The transaction provides Navient with a significant cash infusion of $365 million.
• The deal allows Navient to focus on its core businesses.
• CorroHealth is a good fit for Xtend and its employees, ensuring continuity for the business and its clients.
• The sale will allow Xtend to leverage CorroHealth's broader capabilities and automation tools.

Negatives

• The net gain from the sale is not yet determined and will depend on the final sale proceeds and book value at closing.
• The financial impact of the potential sale of the Government Services business is uncertain at this time.
• The transaction is subject to customary closing conditions, which could potentially delay or prevent the deal from closing.

Risks

• The closing of the transaction is subject to customary conditions, including regulatory approvals and the accuracy of representations and warranties.
• There is a risk that the transaction may not close by the expected date of the end of September 2024, or at all.
• The net gain from the sale is uncertain and depends on various factors.
• The potential sale of the Government Services business is also uncertain, and its financial impact is unknown.
• There is a risk of a Material Adverse Effect occurring before the closing date.

Future Outlook

Navient remains in active discussions about the potential sale of its Government Services businesses, but the financial impact of this process is uncertain. The company is focused on simplifying its operations and enhancing its financial flexibility.

Management Comments

• Dave Yowan, president and CEO of Navient, stated that the transaction is an important achievement in their initiative to explore strategic options for their Business Processing Solutions division and their strategic objectives to simplify their company, reduce their expense base, and enhance their flexibility.
• Pat Leonard, CEO of CorroHealth, expressed pleasure in bringing the Xtend team and technology to CorroHealth, stating that it will allow them to offer an even more fully rounded suite of solutions to their customers.
• Mike Morris, CEO of Xtend Healthcare, stated that the Xtend team is excited to join a world-class health technology leader like CorroHealth and that they will have a broader scope of capabilities and automation tools to offer their customers.

Industry Context

This announcement reflects a trend of companies focusing on core competencies and divesting non-core assets. The healthcare technology sector is experiencing consolidation, with companies like CorroHealth seeking to expand their service offerings through acquisitions.

Comparison to Industry Standards

• The sale of Xtend Healthcare for $365 million is a significant transaction in the healthcare revenue cycle management space.
• Comparable companies in the healthcare technology sector, such as R1 RCM and Optum, have also engaged in acquisitions to expand their market presence.
• The valuation of the transaction will be closely watched by investors to assess the market's perception of healthcare services businesses.
• The transaction is similar to other divestitures where companies are streamlining their operations to focus on core business segments.

Stakeholder Impact

• Shareholders will likely view the transaction positively as it aligns with the company's simplification strategy and provides a cash infusion.
• Employees of Xtend Healthcare will transition to CorroHealth, which is expected to provide them with new opportunities.
• Customers of Xtend Healthcare are expected to experience continuity of service under CorroHealth's ownership.
• Suppliers and creditors of Xtend Healthcare will likely see minimal impact from the transaction.

Next Steps

• The transaction is expected to close by the end of September 2024, subject to customary closing conditions.
• Navient will continue discussions regarding the potential sale of its Government Services businesses.
• The parties will work to satisfy all closing conditions, including regulatory approvals.
• Navient will provide transition services to CorroHealth for a period of time after the closing.

Key Dates

Keywords

Navient, CorroHealth, Xtend Healthcare, Healthcare Services, Business Processing Solutions, Merger, Acquisition, Divestiture, Sale, Revenue Cycle Management